Lymphoma biopsy and pathology reports: what is confirmed, what is pending?
Understand why sample type, lymphoma subtype and pending tests matter, and organize the handoff from a biopsy report to the treatment discussion.
Medical research explained
What clinical trials measure and how treatments such as gene therapy and cell therapy work.
Cancer vaccine types: prevention, treatment and personalized vaccines
Cancer vaccines can prevent infections, target existing disease or use patient-specific immune cells. Learn what the labels do—and do not—tell you.
Cancer vaccines vs CAR-T vs checkpoint inhibitors
These immune treatments act differently and are sometimes combined. Compare their mechanisms, evidence questions and why cross-trial success rates mislead.
How personalized cancer vaccines work—and what “personalized” means
From tumor information to selected antigens and a tested immune response: how individualized mRNA and peptide cancer vaccines differ from generic claims.
An immune response is not automatically a patient benefit
A laboratory or biological result can be valuable without answering every clinical question.
Cancer trial endpoints: response rate, PFS, DFS and overall survival
Decode common cancer-study outcomes, keep response and survival denominators separate, and compare results without turning one endpoint into a cure claim.
Cancer vaccine clinical trials: finding the right official record
Find a cancer-vaccine study by product and trial ID, distinguish recruitment from publication, and understand eligibility, costs and access limits.
Generic, brand and biosimilar medicines: compare the prescription and the bill
Understand FDA equivalence categories, formulation differences and US drug-plan rules before assuming the cheapest advertised medicine matches your prescription.
How to compare medical cost estimates without missing charges
Compare written care estimates by scope, payment basis, included charges and unknowns. Includes a free local tool and US billing-rights sources.
Artificial pancreas vs islet transplantation: automated insulin is not new insulin-producing cells
Compare automated insulin delivery with transplanted islets: source of insulin, measured outcomes, maintenance, immune burden and cost boundaries.
Insulin independence is not the same as a diabetes cure
Understand C-peptide, HbA1c, time in range, severe hypoglycemia and insulin independence—and why cell-therapy headlines must keep them separate.
Lantidra vs zimislecel vs UP421: compare the actual cell therapies
A side-by-side comparison of donor and stem-cell-derived islets, immune strategies, regulatory status and endpoints—without mixing unlike success rates.
A 50% reduction can mean very different things: read the absolute numbers
A complete worked example of relative risk, absolute risk and why the time period matters.
Cataract lens options: monofocal, multifocal and toric are not a price ladder
Compare cataract-lens goals, glasses expectations and quotation terms before assuming a more expensive lens is the right choice.
Cataract surgery cost and Medicare: what the quote should include
Understand Original Medicare cost sharing, separate surgeon and facility charges, glasses coverage and questions about optional lens upgrades.
Glaucoma tests: eye pressure, visual fields and the optic nerve
Understand why one pressure reading cannot settle glaucoma, what different tests measure and how to keep a useful baseline and follow-up record.
Cochlear implant costs: assessment, surgery, programming and coverage
Build a complete cochlear-implant quotation and understand why Medicare eligibility is not just a hearing score or a promise of a zero bill.
Gene therapy vs cochlear implants vs hearing aids
Three hearing technologies compared by mechanism, population, outcomes and evidence—not by an unsupported universal “best treatment” ranking.
Hair-cell regeneration: why hearing-loss gene therapy is not regrowth
Can inner-ear hair cells regrow? Separate noise injury, temporary hearing changes, amplification, cochlear implants and the OTOF gene-therapy result.
OTC vs prescription hearing aids: suitability, returns and total cost
Compare US hearing-aid routes, red flags, return terms, fitting and support before judging a device by its starting price.
OTOF gene therapy: why otoferlin matters for hearing
Explain otoferlin, inner hair-cell signaling and why OTOF-related gene therapy is different from hair-cell regrowth or a universal deafness treatment.
Accelerated approval is not the same as breakthrough designation
One is an authorization pathway; the other supports development and review. Neither is a universal guarantee.
Menopause treatment options: match the treatment to the symptom
Separate systemic HRT, local vaginal treatment and nonhormonal care, then compare benefit, risk, monitoring and the actual service offered.
Assistance, recovery and cure: what paralysis headlines really mean
Distinguish an ability supplied by equipment, a benefit retained without it, neurological recovery and a cure, using actual spinal and speech-BCI evidence.
Spinal stimulation for paralysis: external, implanted and brain-controlled
Compare transcutaneous stimulation, implanted systems and brain–spine interfaces by delivery route, control and demonstrated outcome—not shared terminology.
Compared with what? The question behind every treatment headline
An outcome after treatment and an outcome caused by treatment are different claims. Start with the comparison.
Gene therapy vs gene editing vs cell therapy: the categories overlap
Use three questions—what is delivered, what changes, and where it happens—to understand gene addition, CRISPR editing and engineered-cell treatments.
Regenerative medicine research: regrowth, repair and replacement
Compare tooth regrowth, insulin-producing cell replacement, hearing gene therapy and assistive devices without confusing restored function with new tissue.
A 99% specific test can still produce many false positives
A fictional 10,000-person example explains why a test’s headline accuracy is not the chance that a positive result is correct.
A press release, an abstract and a full paper are different evidence records
They may describe the same study. Treating them as three independent confirmations creates false confidence.
A stopped study is not automatically a failed treatment
Status, reason and results belong in separate fields. Silence is not a substitute for any of them.
Before you share a medical breakthrough, answer these seven questions
A source-first checklist for turning an exciting headline into a claim you can actually evaluate.
Expanded access vs clinical trials: why an experimental drug is not simply available to buy
Understand US expanded access, trial participation, manufacturer supply, FDA and ethics review, and why permission does not guarantee benefit or coverage.
FDA approved vs cleared vs registered: what the words actually establish
Approval, 510(k) clearance, De Novo authorization and establishment registration are different records. Match the product and intended use before accepting a claim.
How to follow a medical research question without collecting endless headlines
Build a small record of meaningful changes: the question, the approach, the evidence and what remains unknown.
Phase 1, Phase 2 and Phase 3: questions, not a progress percentage
Trial phases describe broad research purposes. They do not tell you a treatment’s release date or guarantee its next result.
Who pays for clinical trials? Separate research, routine care and the cost of getting there.
A US-focused guide to trial costs, sponsor-paid research, routine-care insurance, Medicare and travel expenses—with a worked budget example.
Shingles vaccine: who qualifies, timing and what US coverage means
Understand Shingrix eligibility, a delayed second dose, vaccination after shingles and the difference between Medicare Part B and Part D coverage.
Online CBT-I: how to compare programs, support and cost
Distinguish clinician-led CBT-I, structured digital programs, companion apps and sleep trackers before paying for an insomnia service.
Brain implants and AAC: different routes to communication
Compare speech BCIs with eye gaze, communication boards and speech-generating systems without pretending research implants replace every existing option.
Speech BCI accuracy and speed: compare the right measurements
Word error rate, sentence correctness, vocabulary, latency and home use explained with actual BCI examples and a clearly labeled calculation.
What can a study with one or a few participants actually show?
Feasibility, population claims and repeated measurements are different questions. Small does not mean worthless; it means specific.
Can enamel regrow? Remineralization versus growing a new tooth
Early enamel mineral loss can be reversible. A cavity and a missing tooth are different problems. Here is what “regrowth” claims actually mean.
Dental implants vs bridges vs dentures: compare the complete replacement plan
Understand what each tooth-replacement term means, which components a quote includes and why regrowth research is not a present treatment quotation.
Tooth regrowth versus dental implants: evidence, availability and limits
Compare an investigational tooth-development drug with established implant replacement without inventing prices, release dates or a head-to-head trial.
USAG-1 and tooth regeneration: what the drug target means
Why researchers target USAG-1, how an antibody differs from a gene-editing treatment, and why a developmental mechanism is not yet a new tooth.
When will a medical discovery be available? How to read the dates.
Announcement dates, trial estimates and commercial targets answer different questions. Keep them separate.